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Abstract
Xanthogranulomatous cholecystitis (XGC) is an un-
common variant of chronic cholecystitis. The perio-
perative findings in aggressive cases may be indistin-
guishable from those of gallbladder or biliary tract 
carcinomas. Three patients presented mass lesions that 
infiltrated the hepatic hilum, provoked biliary dilatation 
and jaundice, and were indicative of malignancy. 
Surgical excision was performed following oncological 
principles and included extirpation of the gallbladder, 
extrahepatic bile duct, and hilar lymph nodes, as well 
as partial hepatectomy. Postoperative morbidity was 
minimal. Surgical pathology demonstrated XGC and 
absence of malignancy in all three cases. All three 
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patients are alive and well after years of follow-up. 
XGC may have such an aggressive presentation that 
carcinoma may only be ruled out on surgical pathology. 
In such cases, the best option may be radical resection 
following oncological principles performed by expert 
surgeons, in order that postoperative complications may 
be minimized if not avoided altogether.
Key words: Hepaticojejuostomy; Xanthogranulomatous 
cholecystitis; Gallbladder carcinoma; Hepatectomy; 
Hilar cholangiocarcinoma
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Core tip: Though it is a benign disease process, 
xanthogranulomatous cholecystitis may have an agg-
ressive presentation suggestive of a carcinoma of the 
gallbladder or biliary tract. In such cases, the best 
option may be surgical resection performed by expert 
surgeons following oncological principles, in order to 
cure affected patients without provoking postoperative 
morbidity.
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INTRODUCTION
Xanthogranulomatous cholecystitis (XGC) is an 
uncommon variant of chronic cholecystitis chara­
cterized by focal or diffuse severe inflammatory de­
struction of the gallbladder. The incidence of XGC 
is variable and has been described among series of 
cholecystectomies to range between 0.6% and 10%[1]. 
Regarding pathogenesis, the prevailing theory holds 
that chronic outflow obstruction provokes mucosal 
ulceration and/or rupture of Rokitansky­Aschoff sinuses 
and extravasation of mucin and bile into subepithelial 
tissue. Extravasated bile provokes inflammation, and 
macrophages phagocytose bile lipids and cholesterol 
to form ceroid­laden and foamy histiocytes (xanthoma 
cells). The chronic phase is characterized by repair of 
the inflammatory reaction, resulting in fibrosis[2­6]. The 
inflammatory process may be severe and extend into 
adjacent organs, such as the liver, and fistulae may 
develop into surrounding hollow viscuses (namely the 
duodenum and transverse colon)[7].
Given the relative scarcity of the disease process 
and the fact that it may be difficult to differentiate 
from gallbladder carcinoma (GBC) based on clinical 
presentation and preoperative imaging, it is not 
uncommon that patients with XGC are taken to the 
operating room without a clear diagnosis. We describe 
three such cases in which preoperative studies and 
intraoperative findings were highly suggestive for 
malignancy, and radical resection following oncological 
principles was performed. In all three, surgical 




The first patient is a 42­year­old woman with no 
significant past medical history who presents with loss 
of 6 kg over the course of two months and a two­week 
history of epigastric pain and jaundice. No abdominal 
mass is palpated on physical exam. Initial laboratory 
tests are significant for cholestasis, with serum 
bilirubin of 9.3 mg/dL. Computed tomography (CT) 
and magnetic resonance cholangiopancreatography 
(MRCP) imaging reveal a gallbladder with stones and 
asymmetrical malignant­appearing wall thickening and 
a contiguous hepatic hilar mass. The mass infiltrates 
hepatic segment Ⅳb as well as the common and 
bilateral hepatic ducts, with intrahepatic biliary dilatation 
(Figure 1). There is extensive contact between the 
mass and the right portal vein, without any apparent 
plane of separation. No hilar lymphadenopathy is 
observed. Given these imaging findings suggestive 
for resectable biliary tract cancer, the decision is 
made to perform radical surgery. Intraoperatively, 
a petrous lesion enveloping the gallbladder and the 
biliary confluence, with retrograde biliary dilatation, is 
observed. Right trisectionectomy with cholecystectomy 
and complete extirpation of the extrahepatic bile 
duct, hilar lymphadenectomy, and double Roux­en­Y 
hepaticojejunostomy is performed. The specimen is not 
opened, but the proximal and distal bile duct margins 
are sent for perioperative frozen­section analysis 
(negative for malignancy). The intraoperative and 
postoperative courses are uneventful, and the patient 
is discharged home on postoperative day thirteen. 
Pathological analysis of the surgical specimen reveals 
chronic cholecystitis with areas of xanthogranulomatous 
inflammation and absence of malignancy. With over 
ten years of follow­up, the patient remains well and 
asymptomatic.
Case 2
The second patient is a 66­year­old man with no 
significant past medical history that is referred to 
our center for suspected gallbladder versus hilar 
cholangiocarcinoma. The patient arrives at our 
emergency department with complaints of abdominal 
pain, fever, jaundice, acholic stools, and choluria. A 
left­sided external biliary drain has been placed at the 
referring center. The patient is cachectic and presents 
pain on palpation of the right upper quadrant, but 
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no mass is appreciated. Initial laboratory evaluation 
at our center is significant for a serum bilirubin of 3 
mg/dL (status post biliary drainage) and white blood 
cell count of 18.5 × 109/L. The external biliary drain 
is exchanged for an internal­external biliary drain. 
Imaging studies, including CT and MRCP, are performed, 
revealing gallstones and a collapsed gallbladder, with 
focal malignant­appearing wall thickening. There is 
apparent contiguous infiltration of hepatic segment 
IVb, the biliary confluence, the right hepatic duct and 
second­order biliary radicals on the right, and the 
proximal and middle thirds of the common bile duct, 
with intrahepatic biliary dilatation. There is also focal 
contact with the right hepatic artery and a suspicious­
appearing spiculated 1­cm hilar lymph node (Figure 
2). Exploratory laparoscopy is performed to rule out 
peritoneal carcinomatosis and intraabdominal metastatic 
disease followed by laparotomy. Perioperative frozen­
section analysis of the suspicious hilar lymph node is 
negative for malignancy. Radical surgery, including 
right trisectionectomy with cholecystectomy and 
complete extirpation of the extrahepatic bile duct, 
hilar lymphadenectomy, and double Roux­en­Y 
hepaticojejunostomy, is performed. The postoperative 
course is complicated by signs of mild hepatic 
insufficiency (grade 1­2 hepatic encephalopathy and 
peak serum bilirubin of 8.5 mg/dL on postoperative day 
2) and self­limited bile­tinged output in the abdominal 
drain. The patient is ultimately discharged home on 
postoperative day thirteen. Pathological analysis of the 
surgical specimen reveals XGC, without any evidence 
of malignancy. With almost nine years of follow­up, the 
patient remains well and asymptomatic.
Case 3
The third case is a 65­year­old man with active 
cigarette use (one pack per day), and a personal history 
of arterial hypertension, glucose intolerance, and left 
nephrectomy over forty years prior. He presents to 
the emergency department with a five­day history 
of jaundice, choluria, and anorexia. Initial laboratory 
examination is remarkable for a serum bilirubin of 6.8 
mg/dL. Abdominal imaging demonstrates gallstones 
and asymmetric gallbladder wall thickening, affecting 
primarily the infundibulum, with a contiguous hilar 
mass infiltrating bilateral hepatic ducts and contacting 
the right hepatic artery and portal vein, without any 
apparent plane of separation (Figure 3). Intrahepatic 
biliary dilatation was also present. Given a differential 
diagnosis including GBC centered at the infundibulum 
versus hilar cholangiocarcinoma, radical surgery is 
indicated. Perioperative frozen­section analysis of hilar 
lymphadenopathy is negative for malignancy. Ultimately, 
en bloc resection of the gallbladder, hepatic segments 
IVb and V, and the extrahepatic bile duct, as well as hilar 
lymphadenectomy and Roux­en­Y hepaticojejunostomy, 
is performed. The intraoperative and postoperative 
courses are uneventful, and the patient is discharged 
home on postoperative day nine. Pathological analysis 
of the surgical specimen reveals chronic cholecystitis 
with focal areas of xanthogranulomatous inflammation 
and absence of malignancy (Figure 4). The patient 
remains well after almost seven years of follow­up.
DISCUSSION
Herein, we present three cases of aggressive XGC where 
the preoperative studies and intraoperative findings 
demonstrated widely infiltrative disease processes that 
could only be removed by radical surgical excision. 
From a technical standpoint, when severe chronic 
inflammatory changes of XGC have extended into the 
hepatic hilum, resection of adjacent organs and the 
extrahepatic bile duct might be necessary, regardless of 
the ultimate diagnosis. Such radical interventions should 
always be performed by surgeons with appropriate 
expertise, in order that postoperative complications may 
be minimized, if not avoided altogether.
The difficulty in reaching a definitive diagnosis 
preoperatively in cases of aggressive XGC lies in the 
considerable overlap they may present with GBC. 
Both share peak incidences in the sixth and seventh 
Figure 1  Preoperative magnetic resonance cholangiopancreatography from case 1 demonstrates stenosis of the common bile duct and biliary confluence 
(arrow, A) and retrograde biliary dilatation. The transverse section demonstrates diffuse asymmetrical gallbladder wall thickening (arrowhead, B) and contiguous 
hilar mass.
A B
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by the inflammatory process (“xanthogranulomatous 
choledochitis”) may be present, intrahepatic biliary 
dilatation is often absent[7,8]. Findings in our cases that 
were indicative of potentially malignant processes 
include hilar mass lesions, intrahepatic biliary dilatation, 
and images suggestive of vascular infiltration in all 
three.
When the diagnosis is clear at the time of surgical 
intervention, simple cholecystectomy is sufficient 
therapy[1,5,6]. Contiguous organ involvement may ne­
cessitate performing more extensive resection, how­
ever, even when it is known preoperatively that the 
underlying disease process is entirely benign. The three 
cases presented in our series were rather complex, due 
to the presence of widely infiltrative hilar mass lesions 
with associated vascular affectation and retrograde 
biliary dilatation and jaundice, and the interventions 
that were performed were necessary to remove the 
masses and adequately relieve biliary obstruction. In 
general, the laparoscopic approach is not indicated for 
XGC (associated with conversion rates of up to 80%)[1], 
and open approaches are often used initially due to 
suspicion of cancer and/or the anticipation of technical 
difficulty.
It has been repeatedly suggested that intra­
decades of life, arise more commonly in women[8], 
have been associated with cholelithiasis and chronic 
inflammation, and present vague clinical signs and 
symptoms suggestive of biliary colic or acute or 
chronic cholecystitis[9]. Jaundice and cholestasis may 
be seen in both, though jaundice in the setting of GBC 
portends worse prognosis.
None of the three patients in our series had elevated 
serum tumor markers. However, in the diagnosis 
of patients with XGC, serum tumor markers (e.g., 
CA­19.9) are of little utility, as they are not infrequently 
elevated (and in some cases extremely so)[3,9]. Also, 
patients who are Lewis antigen negative (10% of the 
Caucasian population) do not express CA­19.9.
Radiological findings in XGC may include the 
presence of gallstones and gallbladder wall thickening 
(diffuse 80%­90%, focal 10%­20%), intramural 
hypoattenuated nodules, and continuous mucosal 
line enhancement. Though typically considered cha­
racteristic of XGC, intramural nodules may also be 
seen in well­differentiated GBC with abundant mucin 
production[8]. Features more commonly associated with 
malignant pathology, including mass lesion, hepatic 
invasion, and enlarged lymph nodes, may also be 
seen in XGC[5,9]. While involvement of the biliary tree 
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Figure 2  Preoperative magnetic resonance cholangiopancreatography from case 2 demonstrates stenosis of the proximal and middle thirds of the 
common bile duct, biliary confluence (arrowhead, A), and right hepatic duct and second-order biliary radicals, with retrograde biliary dilatation; a 
suspicious-appearing spiculated hilar lymph node is seen on transverse section (arrow, B).
A B
Figure 3  Preoperative CT images from case 3 demonstrating a dilated intrahepatic bile duct (arrow, A) that ends abruptly at the biliary confluence. An ill-
defined hilar mass is seen infiltrating the right hepatic artery (arrow, B) and bilateral hepatic ducts and contacting focally with the portal vein (arrowhead, B).
A B
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operative frozen­section analysis may be useful when 
diagnosis is in doubt, in order to avoid an unnecessarily 
aggressive/“mutilating” intervention[3,4,9]. This approach 
is problematic, however, for a couple of reasons. GBC 
may co­exist with XGC in up to 31% of cases (and 
may actually provoke outflow obstruction or serve as 
an entry point for bile, lipids, etc., into subepithelial 
tissues)[2,4,9­13], and GBC may be missed due to sampling 
error when the two are present simultaneously[4,9,10,14]. 
Also, opening a potentially cancerous gallbladder to 
examine the mucosa risks cutting across tumor and 
disseminating malignant disease. Authors who describe 
doing so relate cases where surgical pathology was 
ultimately benign (XGC), but they typically do not 
describe cases operated in this manner where the 
ultimate diagnosis was GBC. In general, retrospective 
series of rare and highly selected patients that criticize 
the “overtreatment” of this benign disease with an 
oncological resection can be misleading and should be 
regarded with caution. In order to adequately analyze 
the risk for overtreatment, it is important to take into 
account the percentage of patients with aggressive 
radiological features that are ultimately diagnosis with 
GBC, which is the great majority[3].
Complete resection with negative margins remains 
the only curative treatment for patients with GBC. 
According to the National Comprehensive Cancer 
Network (NCCN) 2017 Guidelines for the management 
of GBC, if there is a mass on imaging suspicious for 
GBC, perioperative biopsy is not necessary. Also, 
suspicious mass lesions found during cholecystectomy 
should not be biopsied, as doing so might risk peritoneal 
dissemination. If expertise is available and there is 
convincing clinical evidence of cancer, definitive resection 
(radical cholecystectomy including segments IVb and 
Ⅴ, lymphadenectomy, and extended hepatectomy or 
biliary resection as needed to obtain negative margins) 
should be performed. If expertise is not available, the 
patient should be referred to a center/surgeon capable 
of performing radical/definitive resection[15].
Table 1 provides an overview of single­center series 
(including our own) and case reports published to 
date that include patients undergoing radical resection 
following oncological principles (associating, at a 
minimum, cholecystectomy with resection of hepatic 
segments Ⅳb and Ⅴ and hilar lymphadenectomy) for 
what ultimately turned out to be XGC. Among these 
68 patients, the great majority (72%) presented 
mass lesions and almost half (47%) hepatic invasion. 
Postoperative outcomes were reported for 42 patients, 
Figure 4  Histological examination of the surgical specimens from the three cases of xanthogranulomatous cholecystitis reveals findings of chronic 
cholecystitis and marked inflammatory infiltrate, including lymphocytes, plasma cells, foamy histiocytes, and spindle-shaped cells. A: Focal formations of 
pseudocysts, with multinucleated foreign-body giant cells and cholesterol clefts, are also observed; B: Hyalinization and fibrosis of the gallbladder wall reflects chronic 
inflammation. Typically, the xanthogranulomatous reaction occupies a limited portion of the gallbladder wall, while the remainder shows signs of conventional chronic 
cholecystitis. Polymorphonuclear lymphocytes, reflecting acute inflammation, are also occasionally seen. The mucosa presents focal ulceration and erosion and 
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Table 1  Case series and reports on radical resection for xanthogranulomatous cholecystitis
Ref. n Age (yr) M:F Perioperative findings Intervention Outcome
Agarwal et al[12] 
Gastrointest Surg, 
2013
31 50 ± 13 1:3.3 Cholelithiasis 55% Radical cholecystectomy Postoperative 
mortality 3%Continuous mucosal line enhancement 48%
GB wall thickening 19%
Hepatic invasion 81%
Intramural hypoattenuating nodules 42%
Jaundice 7%
Mass lesion 100%
Rammohan et al[3] 
Gastroenterol Res, 
Pract 2014
16 56 ± 12 1:1.5 Cholelithiasis 69% Radical cholecystectomy NR
Continuous mucosal line enhancement 50%
GB wall thickening 37%
Intramural hypoattenuating nodules 56%
Jaundice 13%
Suzuki H, World J 
Gastroenterol 2015
6 64 ± 10 2:1 Cholelithiasis 83% Radical cholecystectomy NR
Continuous mucosal line enhancement 50%
GB wall thickening 50%
Intramural hypoattenuating nodules 50%
Jaundice 17%
Retrograde biliary dilatation 17%
Nacif Souto L, 2017 3 65 
(42-66)
2:1 Cholelithiasis 100% Cholecystectomy + right 
trisectionectomy + CBD excision + 
hilar lymphadenectomy + double 
hepaticojejunostomy (n = 2), radical 
cholecystectomy + CBD excision 
+ hilar lymphadenectomy + 
hepaticojejunostomy (n = 1)
Asymptomatic after 
≥ 6 yr f/u Continuous mucosal line enhancement 100%
GB wall thickening 100%
Hepatic invasion 67%
Intramural hypoattenuating nodules 33%
Jaundice 100%
Mass lesion 67%
Retrograde biliary dilatation 100%





2:1 Cholelithiasis 100% Cholecystectomy + CBD excision 
+ hepaticojejunostomy (n = 1), 
right hepatectomy + CBD excision 
Asymptomatic after 





1 64 M Hepatic invasion, jaundice, mass lesion, 
retrograde biliary dilatation
Cholecystectomy + right 
hepatectomy + Whipple’s procedure
NR
Garg P, J Gastrointest 
Canc 2014
1 32 F Hepatic invasion, jaundice, mass lesion, 
retrograde biliary dilatation




Semin Liver Dis 2003
1 45 M Cholelithiasis, GB wall thickening, jaundice, 
retrograde biliary dilatation
Whipple’s procedure NR
Kawate S, World J 
Gastroenterol 2006
1 34 F Jaundice, mass lesion, retrograde biliary 
dilatation
Cholecystectomy + extended right 
hepatectomy + CBD excision + 
hepaticojejunostomy
NR
Makino I, World J 
Gastroenterol 2009





1 35 M GB wall thickening, hepatic invasion, jaundice Cholecystectomy + left 
trisectionectomy + CBD excision 






1 75 F Mass lesion, retrograde biliary dilatation Cholecystectomy + extended left 
hepatectomy 
NR
Sharma D, ANZ J 
Surg 2009
1 52 F Cholelithiasis, hepatic invasion, mass lesion Radical cholecystectomy Uneventful 
postoperative course
Spinelli A, World J 
Gastroenterol 2006
1 46 F Cholelithiasis, jaundice, mass lesion, 
retrograde biliary dilatation
Cholecystectomy + right 
hepatectomy + CBD excision + 
segmental duodenal resection 
+ right hemicolectomy + partial 




Total 68 53 ± 7 1:1.7 Cholelithiasis 62% Postoperative 
mortality 1%Continuous mucosal line enhancement 43%
GB wall thickening 35% hepatic invasion 47%
Intramural hypoattenuating nodules 38%
Jaundice 25%
Mass lesion 72%
Retrograde biliary dilatation 15%
Single-center series and case reports published to date in which radical resection following oncological principles was performed for what ultimately 
turned out to be xanthogranulomatous cholecystitis. CBD: Common bile duct; f/u: Follow-up; GB: Gallbladder; NR: Not reported.
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and the majority experienced an uneventful posto­
perative course. There was only one postoperative 
death (1%).
In conclusion, thought it is ultimately a benign 
condition, XGC may have such an aggressive pre­
sentation that carcinoma may only be definitively ruled 
out on surgical pathology. Considering the implications 
of undertreatment when diagnosis is in doubt, the fact 
that both XGC and GBC may co­exist, and the fact 
that lesser surgery might not be technically feasible 
(especially when there is a mass lesion with extensive 
involvement of the biliary tree), the best option may 
be to err on the side of overtreatment. In such cases, 
surgical intervention should be undertaken by a skilled 
surgeon capable of performing radical resection and 
reconstruction and curing the patient of his or her 




Three patients presented with jaundice and variable other symptoms, including 
abdominal pain and weight loss.
Clinical diagnosis
Clinical findings were suggestive of neoplastic processes affecting directly or 
indirectly the biliary tree.
Differential diagnosis
Serum bilirubin was elevated in all three cases, while serum CA-19.9 levels 
were normal.
Laboratory diagnosis
Laboratory tests and imaging studies were performed to clarify the diagnosis.
Imaging diagnosis
Abdominal imaging studies, including CT and magnetic resonance cholangi-
opancreatography, demonstrated widely infiltrative hilar mass lesions with 
associated vascular affectation and retrograde biliary dilatation.
Pathological diagnosis
Since all three patients had aggressive yet apparently resectable lesions, 
surgery was undertaken without previous biopsy.
Treatment
All three interventions were performed according to oncological principles and 
included, at a minimum, radical cholecystectomy, common bile duct excision, 
hilar lymphadenectomy, and hepaticojejunostomy.
Related reports
There are a few previous reports that describe radical resection of very 
aggressive cases of what ultimately turned out to be xanthogranulomatous 
cholecystitis, and most describe little-to-no postoperative morbidity or mortality.
Term explanation
In xanthogranulomatous cholecystitis, mucin and bile are extravasated into 
subepithelial tissues and phagocytosed, resulting in inflammation, xanthoma 
formation, and processes of repair and fibrosis that, in some cases, produce 
pseudotumors that may be confused with malignancy.
Experiences and lessons
For clinicians confronting similar cases, we recommend direct surgical 
intervention performed by an experienced hepatobiliary surgeon capable 
of removing all diseased tissue, reconstructing the patient’s anatomy, and 
effectively curing the patient of his or her disease process.
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